NCT03253861

Brief Summary

Severe acute pancreatitis is a common reason for intensive care unit (ICU) admission and is associated with prolonged hospital stays and high morbidity and mortality rates. The Atlanta classification differentiates mild, moderate, and severe acute pancreatitis, and each of these categories correlates with morbidity and mortality. Mortality remains high, between 10% and 39%, in severe and moderately severe acute pancreatitis. After the first week, about 30% of patients with necrotizing pancreatitis develop infected pancreatic necrosis (IPN). IPN is a risk factor for mortality.The treatment of IPN combines antibiotics with interventions to remove the infected intra-abdominal material, preferably using minimally invasive techniques such as percutaneous and endoscopic drainage, which have been proven beneficial. In several studies biological markers such as procalcitonin and interleukin 8 were effective in predicting IPN. However, few clinical risk factors for IPN have been reported. Identifying risk factors may help to improve standardized strategies for early diagnosis and treatment, and then patients outcome. Our primary objective was to identify risk factors for IPN in patients admitted to the ICU for acute pancreatitis. Our secondary objective was to describe the management and outcomes of IPN

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
148

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jun 2016

Shorter than P25 for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2016

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2017

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2017

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

August 16, 2017

Completed
2 days until next milestone

First Posted

Study publicly available on registry

August 18, 2017

Completed
Last Updated

August 18, 2017

Status Verified

August 1, 2017

Enrollment Period

7 months

First QC Date

August 16, 2017

Last Update Submit

August 16, 2017

Conditions

Keywords

Acute necrotizing pancreatitisAcute pancreatitisSepsis/complicationsInfectionOrgan Dysfunction ScoresDrainageCathetersAntibioticsMultiresistant organismPancreatitis/complicationsPancreatitis/diagnosisPancreatitis/surgeryPancreatitis/therapyPancreatitis, Acute Necrotizing/complicationsPancreatitis, Acute Necrotizing/surgeryPancreatitis, Acute Necrotizing/therapy

Outcome Measures

Primary Outcomes (1)

  • Risk factors of infected pancreatic necrosis

    Potential risk factors included patient demographics, disease severity, complications, morphology on CT, and details of the drainage procedure. Univariate analyses examined potential risk factors on outcome (catheter drainage failure). Then, using multiple logistic regression analysis, factors achieving P≤0.1 in univariate analyses were entered into the model predicting the risk of catheter drainage failure

    4 months

Secondary Outcomes (1)

  • Risk factors of mortality

    4 months

Study Arms (2)

control patients

patients without an infected pancreatic necrosis

Other: No intervention

Case patients

patients with an infected pancreatic necrosis

Other: No intervention

Interventions

No intervention

Case patientscontrol patients

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adult patients with acute necrotizing pancreatitis admitted in an ICU between January 2012 and December 2015 for moderately severe or severe acute pancreatitis

You may qualify if:

  • Adult patients (age \>18 years) with acute necrotizing pancreatitis admitted in an ICU between January 2012 and December 2015 for moderately severe or severe acute pancreatitis were included.
  • Organ failure that resolves within 48 h (transient organ failure) and/or local or systemic complications without persistent organ failure or persistent organ failure (\>48 h)

You may not qualify if:

  • mild acute pancreatitis, defined as no organ failure or local complication (No necrosis or peri-pancreatic collection)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Garret C, Canet E, Corvec S, Boutoille D, Peron M, Archambeaud I, Le Thuaut A, Lascarrou JB, Douane F, Lerhun M, Regenet N, Coron E, Reignier J. Impact of prior antibiotics on infected pancreatic necrosis microbiology in ICU patients: a retrospective cohort study. Ann Intensive Care. 2020 Jun 15;10(1):82. doi: 10.1186/s13613-020-00698-0.

MeSH Terms

Conditions

Pancreatitis, Acute NecrotizingInfectionsPancreatitisSepsisDisease

Condition Hierarchy (Ancestors)

Pancreatic DiseasesDigestive System DiseasesSystemic Inflammatory Response SyndromeInflammationPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Charlotte Garret, MD

    Nantes CHU

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 16, 2017

First Posted

August 18, 2017

Study Start

June 1, 2016

Primary Completion

January 1, 2017

Study Completion

June 1, 2017

Last Updated

August 18, 2017

Record last verified: 2017-08